Protective Effects of Salvianolate on Myocardial Injury or Myocardial Infarction after Elective Percutaneous Coronary Intervention in NSTE-ACS Patients: A Randomized Placebo-Controlled Trial-Reference-Cited by-同舟云学术

Protective Effects of Salvianolate on Myocardial Injury or Myocardial Infarction after Elective Percutaneous Coronary Intervention in NSTE-ACS Patients: A Randomized Placebo-Controlled Trial

Published:2020-06-22 Issue:9 Volume:26 Page:656-662
ISSN:1672-0415
Container-title:Chinese Journal of Integrative Medicine
language:en
Short-container-title:Chin. J. Integr. Med.

Author:

Ou Yang,Sun Sheng-jia,Shi Hai-ming,Luo Jian-feng,Luo Xin-ping,Shen Yun-zhi,Chen Yu-fei,Fan Wei-hu,Liu Hong-ying,Shen Wei

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Complementary and alternative medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11655-020-2728-0.pdf

Reference22 articles.

1. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. ESC Scientific Document Group. Fourth universal definition of myocardial infarction (2018). Eur Heart J 2019;40:237–269.

2. Zeitouni M, Silvain J, Guedeney P, Kerneis M, Yan Y, Overtchouk P, et al. Periprocedural myocardial infarction and injury in elective coronary stenting. Eur Heart J 2018;39:1100–1109.

3. Meng C, Zhuo XQ, Xu GH, Liu JL. Protection of salvianolate against atherosclerosis via regulating the inflammation in rats. J Huazhong Univ Sci Technolog Med Sci 2014;34:646–651.

4. Liu L, Li J, Zhang Y, Zhang S, Ye J, Wen Z, et al. Salvianolic acid B inhibits platelets as a P2Y12 antagonist and PDE inhibitor: evidence from clinic to laboratory. Thromb Res 2014;134:866–876.

5. Han B, Zhang X, Zhang Q, Zhao G, Wei J, Ma S, et al. Protective effects of salvianolate on microvascular flow in a porcine model of myocardial ischaemia and reperfusion. Arch Cardiovasc Dis 2011;104:313–324.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress on the natural products in the intervention of myocardial infarction;Frontiers in Pharmacology;2024-08-22

2. Effects of Salvianolate Injection on the Pharmacodynamics and Pharmacokinetics of Warfarin in Rats In vivo;Current Analytical Chemistry;2024-06

3. THE EFFECT OF SALVIANOLATE ON CARDIOMYOCYTE REMODELING IMPROVEMENT AFTER MYOCARDIAL INFARCTION THROUGH CALCINEURIN/NUCLEAR FACTOR C3 OF THE ACTIVATED T CELL/B-MYOSIN HEAVY CHAIN PATHWAY REGULATION;J PHYSIOL PHARMACOL;2022